109135 ⎘
Structure or type of the nucleic acid; Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
Sub-classes:LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF
#2IONIZABLE LIPID CONTAINING BIODEGRADABLE DISULFIDE BOND AND LIPID NANOPARTICLES COMPRISING SAME
#3ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE
#4TOEHOLD EXCHANGE RIBOREGULATOR GATE AND REGULATING PROTEIN TRANSLATION WITH TOEHOLD EXCHANGE RIBOREGULATOR
#5TRANS-SPLICING RIBOZYME SPECIFIC TO APOE4 RNA AND USE THEREOF
#6METHOD OF TREATING, AMELIORATING AND/OR PREVENTING POLYCYSTIC KIDNEY DISEASE
#7PROTEIN TRANSLATION SYSTEM
#8METHODS AND COMPOSITIONS FOR TRANS-SPLICING UTILIZING SMALL NUCLEAR RNAS AND SMALL NUCLEOLAR RNAS
#9TYPE I-D CRISPR-GUIDED TRANSPOSON WITH ENHANCED GENOME EDITING
#10METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#11GENOME INSERTIONS IN CELLS
#12COMPOSITIONS AND METHODS FOR CIRCULAR RNA AFFINITY PURIFICATION
#13METHODS OF TREATING CHOLANGIOCARCINOMA
#14LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE, KIT CONTAINING LIPID PARTICLE, AND ACTIVE AGENT DELIVERY METHOD USING LIPID PARTICLE
#15PRODUCTION OF CIRCULAR POLYRIBONUCLEOTIDES IN A PROKARYOTIC SYSTEM
#16METHOD FOR TREATING CLONAL HEMATOPOIETIC BLOOD DISORDERS
#17TRANS-SPLICING RNA (TSRNA)
#18COMPOSITIONS AND METHODS FOR TREATING CANCERS
#19COMPOSITIONS AND METHODS RELATING TO PEDIATRIC NEUROMUSCULAR DISEASES AND NEUROGENERATIVE DISORDERS
#20RNA MOLECULE
#21METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#22HIF1A OR GLUT1 INHIBITION IN INFLAMMATORY SKIN DISEASES
#23OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
#24PEPTIDE HAVING INDEPENDENTLY STABILIZED HYDROPHOBIC ALPHA HELIX, PEPTIDE COMPLEX COMPRISING SAME AND USES THEREOF
#25STAUFEN1 REGULATING AGENTS AND ASSOCIATED METHODS
#26LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF
#27TKTL1 INHIBITORS FOR ANTIVIRAL THERAPY
#28CANCER-SPECIFIC TRANS-SPLICING RIBOZYME AS GENE THERAPY PRODUCT COMBINED WITH RADIOTHERAPY
#29Compositions and Methods for Treatment and Prevention of Misfolded Proteins
#30PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS
#31CTLA-4 APTAMER CONJUGATES
#32METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#33METHODS FOR MODULATING CAS-EFFECTOR ACTIVITY
#34TM4SF19 INHIBITOR AND USES THEREOF
#35COMPOSITION FOR TREATING OSTEOARTHRITIS
#36INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY
#37ENGINEERED BI-STABLE TOGGLE SWITCH AND USES THEREOF
#38TM4SF19 INHIBITOR AND USES THEREOF
#39RIBOSOMAL RNA SCAFFOLDS FOR PROTEIN-FREE AND TEMPLATE-FREE SYNTHESIS OF PEPTIDES
#40METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#41ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR THE TREATMENT OF PAIN
#42IMMUNO-ONCOLOGY TARGETS TO IMPROVE T-CELL METABOLIC RESPONSE
#43HIGH-THROUGHPUT PRECISION GENOME EDITING
#44Methods of treating cholangiocarcinoma
#45TARGETED RNA EDITING BY LEVERAGING ENDOGENOUS ADAR USING ENGINEERED RNAS
#46Methods and compositions for transducing lymphocytes and regulating the activity thereof
#47ARC-BASED CAPSIDS AND USES THEREOF
#48RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
#49COMPOSITION COMPRISING OSTEOPONTIN INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF NEURODEGENERATIVE DISEASE
#50TARGETING ZNF410 FOR FETAL HEMOGLOBIN INDUCTION IN BETAHEMOGLOBINOPATHIES
#51Composition for regulating expression of PROX1 or expression of telomerase reverse transcriptase comprising activity regulator or method for screening telomerase reverse transcriptase regulator
#52METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES
#53METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#54REGULATION OF GENE EXPRESSION VIA APTAMER-MEDIATED CONTROL OF SELF-CLEAVING RIBOZYMES
#55SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY
#56DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES
#57COMPOSITION FOR PREVENTING OR TREATING DISEASE CAUSED BY MUSCLE LOSS, COMPRISING AGENT INHIBITING PHF20
#58METHOD FOR TREATING CARDIOVASCULAR DISEASE
#59USE OF CDON INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
#60RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
#61Compositions comprising reversibly modified oligonucleotides and uses thereof
#62COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A MYCOBACTERIUM TUBERCULOSIS INFECTION
#63ENHANCED PRODUCTION OF HISTIDINE, PURINE PATHWAY METABOLITES, AND PLASMID DNA
#64SWITCHABLE CAS9 NUCLEASES AND USES THEREOF
#65CATALYTIC NUCLEIC ACID-BASED GENETIC ENGINEERING METHOD
#66TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
#67METHOD FOR TREATING ANGELMAN SYNDROME AND RELATED DISORDERS
#68METHODS AND COMPOSITIONS TO PROMOTING RETINAL REGENERATION USING PROX1 MIGRATION INHIBITOR AS ACTIVE INGREDIENT
#69METHODS OF TREATING OR SELECTING A TREATMENT FOR A SUBJECT RESISTANT TO TNF INHIBITOR USING A NLRP3 ANTAGONIST
#70METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#71COMPOSITION FOR PREVENTING OR TREATING CANCER
#72SINGLE INPUT MULTIPLEX DECISION SYSTEMS AND METHODS OF USING THE SAME
#73CTLA-4 aptamer conjugates
#74Targeted RNA editing by leveraging endogenous ADAR using engineered RNAs
#75Trans-splicing ribozyme targeting rhodopsin transcript and uses thereof
#76ARC-BASED CAPSIDS AND USES THEREOF
#77BARLEY STRIPE MOSAIC VIRUS-BASED GENE EDITING VECTOR SYSTEM
#78AGENT USING HSP47 INHIBITOR TO SUPPRESS METASTASIS
#79Compositions for Transfecting Resistant Cell Types
#80Methods of treating cholangiocarcinoma
#81METHOD OF TREATING WASTING DISORDERS
#82METHOD FOR TREATING CARDIOVASCULAR DISEASE
#83INHIBITION OF CATALYTIC SITE COMMON TO MULTIPLE 3 ALPHA-OXIDOREDUCTASES FOR TREATMENT OF PROSTATE CANCER
#84ENGINEERED BI-STABLE TOGGLE SWITCH AND USES THEREOF
#85Staufen1 regulating agents and associated methods
#86NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING
#87TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#88DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY
#89METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#90Detection of nucleic acids
#91Anti-connexin compounds targeted to connexins and methods of use thereof
#92Liposomal particles, methods of making same and uses thereof
#93Method of treating inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) or gluten hypersensitivity by administering an elastase 2A (ELA2A) inhibitor
#94Oligonucleotide compositions and methods thereof
#95METHODS FOR TREATING ALCOHOLIC LIVER DISEASE, ALCOHOL-INDUCED BRAIN INJURY AND REDUCING ALCOHOL ADDICTION
#96Loss of function alleles of PtEPSP-TF and its regulatory targets in rice
#97CTLA-4 aptamer conjugates
#98Molecular sensor selection
#99Dynamin 2 inhibitor for the treatment of centronuclear myopathies
#100METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#101Killer cell capable of efficiently and stably expressing antibody, and uses thereof
#102COMPOSITIONS AND METHODS FOR REGULATION OF IMMUNE CELL ACTIVATION AND PROLIFERATION
#103Switchable CAS9 nucleases and uses thereof
#104COMPOSITIONS AND METHODS FOR REGULATION OF GENE EXPRESSION WITH, AND DETECTION OF, FOLINIC ACID AND FOLATES
#105Anti-connexin compounds targeted to connexins and methods of use thereof
#106Methods for RNA promoter identification
#107Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
#108Liposomal particles, methods of making same and uses thereof
#109Ribozyme with tRNA synthetase activity and methods of manufacturing and using the same
#110High-throughput precision genome editing
#111Compositions and methods for reducing neointima formation
#112Compositions for transfecting resistant cell types
#113CANCER TREATMENT BY GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 INHIBITION
#114METHODS OF TREATEMENT OF CANCER DISEASE BY TARGETTING TUMOR ASSOCIATED MACROPHAGE
#115ANTAGONIST OF MINERALOCORTICOID RECEPTOR FOR THE TREATMENT OF OSTEOARTHRITIS
#116MOLECULAR RE-ENGINEERING OF EXCITATION-INHIBITION BALANCE IN MEMORY CIRCUITS
#117CTLA-4-targeting trans-splicing ribozyme for delivery of chimeric antigen receptor, and use thereof
#118Anti-connexin compounds targeted to connexins and methods of use thereof
#119Nucleic acid molecules inducing RNA interference, and uses thereof
#120Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
#121Compositions comprising reversibly modified oligonucleotides and uses thereof
#122Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)
#123Recombinant bacillus subtilis for increasing production of acetylglucosamine and construction method thereof
#124miRNA for treatment of breast cancer
#125Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
#126RNA-directed DNA cleavage by the Cas9-crRNA complex
#127Detection of nucleic acids
#128PROCESS FOR THE IN VIVO PRODUCTION OF RNA IN A HOST CELL
#129Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#130PROTECTED DNA TEMPLATES FOR GENE MODIFICATION AND INCREASED HOMOLOGOUS RECOMBINATION IN CELLS AND METHODS OF USE
#131Amino acid-modified nucleic acid and utilization thereof
#132Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates
#133Compositions and methods of using anti-mullerian hormone for treatment of infertility
#134Molecular sensor selection
#135RNA-directed DNA cleavage by the Cas9-crRNA complex
#136Cancer specific-splicing ribozyme and use thereof
#137Recombinant for producing acetylglucosamine and construction method thereof
#138METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#139Methods for RNA promoter identification
#140Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
#141METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASES
#142Particle-nucleic acid conjugates and therapeutic uses related thereto
#143Hepcidin antagonists for use in the treatment of inflammation
#144Compositions and methods using capsids resistant to hydrolases
#145Compositions and methods to promote erythropoiesis
#146Methods and compositions for transducing lymphocytes and regulating the activity thereof
#147Nucleic acid molecules inducing RNA interference, and uses thereof
#148Method and treatment of recurring endometrial cancer with an inhibitor of USP14
#149POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#150Self-cleaving ribozymes and uses thereof
#151PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS
#152Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
#153Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
#154RNA EDITING BIOMARKERS FOR DIAGNOSIS, PHARMACOLOGICAL SCREENING AND PROGNOSTICATION IN CANCER
#155Methods for the treatment of cardiovascular fibrosis
#156Methods of treating fragile X syndrome and related disorders
#157Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses
#158METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#159Algal mutants with increased lipid productivity
#160Nucleic acid enzyme substrates
#161Nucleic acid fragment binding to target protein
#162Compositions and methods to promote erythropoiesis
#163Method for treatment of heart failure
#164Methods for treating diet-induced obesity by decreasing or inhibiting P2Y2 purinergic receptor expression or activity
#165Molecular re-engineering of excitation-inhibition balance in memory circuits
#166Detection of nucleic acids
#167Ribozyme with tRNA synthetase activity and methods of manufacturing and using the same
#168Synthesis of transcripts using Syn5 RNA polymerase
#169Modulators of intracellular chloride concentration for treating down syndrome
#170Liposomal particles, methods of making same and uses thereof
#171SnoRNA, compositions and uses
#172Dynamin 2 inhibitor for the treatment of centronuclear myopathies
#173Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury
#174Switchable Cas9 nucleases and uses thereof
#175Nanocomplexes for co-delivering a drug and siRNA and uses thereof
#176Antisense-based small RNA agents targeting the Gag open reading frame of HIV-1 RNA
#177C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
#178Compositions and methods using capsids resistant to hydrolases
#179Protection against ionizing radiation and chemotherapy toxicity via latexin regulation
#180Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease
#181Methods and compositions for stimulating reepithelialisation during wound healing
#182Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#183Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#184Compositions and methods for reducing neointima formation
#185METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN
#186METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1
#187Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
#188Therapeutic agent for fibroid lung
#189MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION
#190Composition for gene delivery comprising chitosan and liquid crystal formation material
#191Methods of treating cholangiocarcinoma
#192Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy
#193Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#194Composition and methods for the prevention and treatment of diet-induced obesity
#195CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION
#196Nanotubes as carriers of nucleic acids into cells
#197RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
#198Methods for producing a population of pancreatic beta-cells
#199CTLA-4 aptamer siRNA species
#200WOUND HEALING
#201Particle-nucleic acid conjugates and therapeutic uses related thereto
#202METHODS FOR DIAGNOSING AND TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
#203Compositions and methods for inducing myoblast differentiation and myotube formation
#204Composition and methods for reduced scarring and treatment of fibrosis
#205Reducing galectin-12 activity to influence the cell function of human sebocytes
#206Nucleic acid fragment binding to target protein
#207Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage
#208Composition for gene delivery
#209LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#210Extended DNA-sensing GRNAS
#211MRNA-sensing switchable gRNAs
#212Switchable gRNAs comprising aptamers
#213Neurofibromatoses therapeutic agents and screening for same
#214SELF-CLEAVING RIBOZYMES AND USES THEREOF
#215RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
#216Nucleic acid enzyme substrates
#217Methods for diagnosing and treating neuroendocrine cancer
#218RNA-directed DNA cleavage by the Cas9-crRNA complex
#219Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms
#220RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE
#221Heptamer-type small guide nucleic acids inducing apoptosis of human leukemia cells
#222Compositions and methods to promote erythropoiesis
#223Cottonseed oil and uses
#224Use of human NLK gene and associated drugs thereof
#225Anti-connexin compounds targeted to connexins and methods of use thereof
#226Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
#227pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles
#228Nanotubes as carriers of nucleic acids into cells
#229Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer
#230Nucleic acid molecules inducing RNA interference, and uses thereof
#231Compositions and methods for treatment of drug resistant multiple myeloma
#232Pharmaceutical composition for transcolonic absorption
#233Multicomponent nucleic acid enzymes and methods for their use
#234OSTEOARTHRITIS BIOMARKERS AND USES THEREOF
#235THERAPEUTIC AGENT FOR FIBROID LUNG
#236Heparanase splice variant
#237RNA interference target for treating AIDS
#238Antibodies that bind polypeptides involved in the process of bone remodeling
#239Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
#240Nucleic acid based fluorescent sensor for mercury detection
#241Anti-connexin compounds targeted to connexins and methods of use thereof
#242Antibodies that bind polypeptides involved in the process of bone remodeling
#243EXPONENTIAL ISOTHERMAL SELF-SUSTAINED REPLICATION OF AN RNA ENZYME
#244Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#245RNA INTERFERENCE TARGET FOR TREATING AIDS
#246Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
#247Cottonseed oil and uses
#248Method for producing a cell and/or tissue and/or disease phase specific medicament
#249Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#250Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels
#251Reactivation of axon growth and recovery in chronic spinal cord injury
#252THERAPEUTIC AGENT FOR FIBROID LUNG
#253TREATMENT OF RHEUMATOID ARTHRITIS
#254IL-17 Homologous Polypeptides and Therapeutic Uses Thereof
#255SELF-CLEAVING RIBOZYMES AND USES THEREOF
#256METHOD OF INCREASING METABOLISM
#257Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists
#258Fas/FasL or other death receptor targeted methods and compositions for killing tumor cells
#259Antisense Oligonucleotides Against VR1
#260Methods and compositions for regulated expression of multiple nucleic acids
#261Method of treatment or prophylaxis of inflammatory pain
#262PROTEIN
#263Compositions And Methods For Reducing Cancer And Inflammation
#264Method for the production of a cell and/or tissue and/or disease phase specific medicament
#265Methods of treatment of skin ulcers
#266Dnazymes and sensors incorporating the same
#267Genetic control of mammalian cells with synthetic RNA regulatory systems
#268Nucleic acids for inhibiting hairless protein expression and methods of use thereof
#269METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION
#270RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#271Methods and Compositions for Treating Cancer
#272Osteoarthritis biomarkers and uses thereof
#273CADHERIN-11-MEDIATED MODULATION OF HAIR GROWTH
#274Wound healing
#275Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof
#276Protein Complex and Uses
#277METHOD OF TREATMENT AND PROPHYLAXIS
#278RNA INTERFERENCE COMPOSITIONS AND METHODS
#279Modulators of cell migration and methods of identifying same
#280Multivalent rna nanoparticles for delivery of active agents to a cell
#281CHIMERIC TRANSFER RNA AND USE THEREOF FOR THE PRODUCTION OF RNA BY A CELL
#282Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#283HEPATITIS C ANTIVIRALS
#284Inhibition of tumor growth and invasion by anti matrix metalloproteinase DNAzymes
#285Modulation of neuroglia-derived BDNF in the treatment and prevention of pain
#286HEPATITIS C ANTIVIRALS
#287Nucleic acid agents for downregulating H19, and methods of using same
#288RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#289Wound healing
#290Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#291RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
#292RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#293Methods for regulation of p53 translation and function
#294Modular polynucleotides for ligand-controlled regulatory systems
#295Nucleic acid agents for downregulating H19 and methods of using same
#296IL-17 homologous polypeptides and therapeutic uses thereof
#297IL-17 homologous polypeptides and therapeutic uses thereof
#298RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#299RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)
#300RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)